Bactiguard Holding AB
STO:BACTI B

Watchlist Manager
Bactiguard Holding AB Logo
Bactiguard Holding AB
STO:BACTI B
Watchlist
Price: 34.4 SEK Market Closed
Market Cap: 1.2B SEK
Have any thoughts about
Bactiguard Holding AB?
Write Note

Operating Margin
Bactiguard Holding AB

-19.4%
Current
-27%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-19.4%
=
Operating Profit
-49.4m
/
Revenue
255m

Operating Margin Across Competitors

Country SE
Market Cap 1.2B SEK
Operating Margin
-19%
Country JP
Market Cap 6.8T JPY
Operating Margin
28%
Country CH
Market Cap 37.9B CHF
Operating Margin
13%
Country DK
Market Cap 200.9B DKK
Operating Margin
27%
Country US
Market Cap 16.9B USD
Operating Margin
17%
Country KR
Market Cap 9.9T KRW
Operating Margin
-245%
Country CA
Market Cap 6.9B USD
Operating Margin
4%
Country CN
Market Cap 48.6B CNY
Operating Margin
46%
Country US
Market Cap 6.3B USD
Operating Margin
32%
Country US
Market Cap 6.1B USD
Operating Margin
12%
Country UK
Market Cap 4.8B GBP
Operating Margin
13%
No Stocks Found

Bactiguard Holding AB
Glance View

Market Cap
1.2B SEK
Industry
Health Care

Bactiguard Holding AB is a medical device company, which engages in the development and supply of infection protection solutions. The company is headquartered in Stockholm, Stockholm and currently employs 188 full-time employees. The company went IPO on 2014-06-19. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. The company consists of the noble metals: gold, palladium and silver, which reduces the adhesion of bacteria to the coated surfaces. Its product portfolio includes: BIP Foley Catherer, made from medical grade latex, and BIP Foley Catheter - Silicone, used for drainage and irrigation of the bladder; BIP Endotracheal Tube, for general anesthesia, intensive care, and emergency medicine for airway management and mechanical ventilation; and BIP Central Venous Catherer, made of polyurethane and used to administer drugs and intravenous solutions, monitor pressure and blood sampling. The firm is also present in Portugal, via a distribution agreement with Socime Medical Ltd, and Zambia.

BACTI B Intrinsic Value
28.27 SEK
Overvaluation 18%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-19.4%
=
Operating Profit
-49.4m
/
Revenue
255m
What is the Operating Margin of Bactiguard Holding AB?

Based on Bactiguard Holding AB's most recent financial statements, the company has Operating Margin of -19.4%.